Recursion Pharmaceuticals Inc ( RXRX ) shares are rising in Thursday’s after-hours session following the company’s first-quarter financial results. Q1 Earnings: Recursion reported first-quarter revenue of $13.491 million, which beat analyst estimates of $12.65 million, according to Benzinga Pro. The company reported a quarterly loss of 39 cents per share, which beat estimates for a loss of 42 cents per...

05:27 PM EDT, 05/09/2024 (MT Newswires) -- Joseph D Mansueto, 10% Owner, Director, Executive Chairman, on May 07, 2024, sold 7,758 shares in Morningstar ( MORN ) for $2,330,767. Following the Form 4 filing with the SEC, Mansueto has control over a total of 15,628,731 shares of the company, with 10,726,068 shares held directly and 4,902,663 controlled indirectly. SEC Filing:...

05:22 PM EDT, 05/09/2024 (MT Newswires) -- Pascal Deschatelets, Chief Scientific Officer, on May 08, 2024, sold 78,907 shares in Apellis Pharmaceuticals ( APLS ) for $3,341,848. Following the Form 4 filing with the SEC, Deschatelets has control over a total of 1,115,983 shares of the company, with 1,115,983 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1492422/000112760224014811/xslF345X03/form4.xml Price: 42.66, Change: +0.14, Percent...

05:25 PM EDT, 05/09/2024 (MT Newswires) -- ARC Resources ( AETUF ) Thursday said its first-quarter profit fell 68% on lower natural-gas prices. The Western Canadian oil and gas producer said it earned C$185.4 million, or C$0.31 per share, down from C$574.9 million, or C$0.93, in the year-prior quarter. Revenue was not disclosed . The company said its first quarter...